Search
for
Sort by
Research 241–270 of 889
- Holistic management plan for polycystic ovarian syndrome (PCOS): A systematic literature review
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Understanding Polycystic Ovary Syndrome
- Prevalence of Depression and Anxiety in Women with Polycystic Ovary Syndrome (PCOS) and Associated Factors: A Cross-Sectional Study
- A review on follicular targeting for the treatment of hirsutism
- Androgen effects on the skin
- Alopecia and its medical management
- Venous thromboembolism and women's health
- Caring for women with polycystic ovary syndrome
- Plant-based approaches in the management of polycystic ovary syndrome: A review
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Treatment of Hair Loss
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Molecular mechanisms of androgenetic alopecia
- Endocrinology of Transgender Medicine
- Estrogens and aging skin
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Sexuality in premature ovarian insufficiency
- Stem cells and aberrant signaling of molecular systems in skin aging
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Polycystic ovary syndrome in adolescents
- Cross-sex hormone therapy for gender dysphoria
- What is the Rationale for Androgen Therapy for Women?
- CLINICAL UPDATES IN HAIR
- THE USE OF DERMAL PAPILLA CELLS IN STUDIES OF NORMAL AND ABNORMAL HAIR FOLLICLE BIOLOGY
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Determining the normal cut-off levels for hyperandrogenemia in Chinese women of reproductive age